Statements (43)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:opioid |
| gptkbp:activeIngredient |
gptkb:meperidine
|
| gptkbp:approvedBy |
1940s
|
| gptkbp:ATCCode |
N02AB02
|
| gptkbp:brand |
gptkb:Pethidine
gptkb:meperidine Alodan Centralgin Dispadol Dolantin Dolestine Dolosal Mepergan Meperidine Hydrochloride Opidol Pethidine Hydrochloride Pethilorfan |
| gptkbp:chemicalFormula |
C15H21NO2
|
| gptkbp:contraindication |
MAOI use
severe respiratory insufficiency |
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_II_(US)
|
| gptkbp:developedBy |
gptkb:Sanofi
|
| gptkbp:excretion |
gptkb:kidney
|
| gptkbp:genericName |
gptkb:meperidine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:riskFactor |
addiction
overdose |
| gptkbp:routeOfAdministration |
oral
intramuscular subcutaneous intravenous |
| gptkbp:sideEffect |
nausea
constipation dizziness drowsiness respiratory depression |
| gptkbp:usedFor |
pain management
|
| gptkbp:bfsParent |
gptkb:Meperidine
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Demerol
|